These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27529773)

  • 1. N-Acetylcysteine for Treating Compulsive Behavior: An Updated Meta-Analysis.
    Shiozawa P; Generoso MB; Taiar I; Cordeiro Q
    J Clin Psychopharmacol; 2016 Oct; 36(5):523-4. PubMed ID: 27529773
    [No Abstract]   [Full Text] [Related]  

  • 2. N-acetyl cysteine in the treatment of grooming disorders.
    Odlaug BL; Grant JE
    J Clin Psychopharmacol; 2007 Apr; 27(2):227-9. PubMed ID: 17414258
    [No Abstract]   [Full Text] [Related]  

  • 3. N-acetylcysteine in the treatment of compulsive sexual behavior disorder: A case series.
    Blum AW; Grant JE
    J Psychiatr Res; 2022 Oct; 154():203-206. PubMed ID: 35952519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant Therapies for Ulcerative Dermatitis: A Potential Model for Skin Picking Disorder.
    George NM; Whitaker J; Vieira G; Geronimo JT; Bellinger DA; Fletcher CA; Garner JP
    PLoS One; 2015; 10(7):e0132092. PubMed ID: 26167859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of acetylcysteine for preventing contrast-induced nephropathy].
    Schaad N; Barghouth G
    Rev Med Suisse; 2005 Jun; 1(25):1693-6. PubMed ID: 16117036
    [No Abstract]   [Full Text] [Related]  

  • 6. N-acetylcysteine improves the clinical conditions of mustard gas-exposed patients with normal pulmonary function test.
    Ghanei M; Shohrati M; Jafari M; Ghaderi S; Alaeddini F; Aslani J
    Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):428-32. PubMed ID: 18801028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ulcers caused by bullous morphea: successful therapy with N-acetylcysteine and topical wound care.
    Rosato E; Veneziano ML; Di Mario A; Molinaro I; Pisarri S; Salsano F
    Int J Immunopathol Pharmacol; 2013; 26(1):259-62. PubMed ID: 23527731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating compulsive behaviors in dermatology.
    Koo JY
    West J Med; 1991 Nov; 155(5):523. PubMed ID: 1815402
    [No Abstract]   [Full Text] [Related]  

  • 9. N-Acetylcysteine in the prevention of ototoxicity.
    Tepel M
    Kidney Int; 2007 Aug; 72(3):231-2. PubMed ID: 17653228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a place for N-acetylcysteine in the treatment of septic shock?
    Del Sorbo L; Zhang H
    Crit Care; 2004 Apr; 8(2):93-5. PubMed ID: 15025765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antioxidants support the intrinsic physical response. Interview by Heinz W. Weismann].
    Magnussen H
    Pneumologie; 1996 Jan; 50(1):VII. PubMed ID: 8774929
    [No Abstract]   [Full Text] [Related]  

  • 12. N-acetylcysteine in intestinal reperfusion injury: an experimental study in rats.
    Hazinedaroglu SM; Dulger F; Kayaoglu HA; Pehlivan M; Serinsoz E; Canbolat O; Erverdi N
    ANZ J Surg; 2004 Aug; 74(8):676-8. PubMed ID: 15315570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Acetylcysteine Protection in COPD: An Alternative Mechanism of Action.
    Wu W; Awab A; Metcalf JP
    Chest; 2014 Jan; 145(1):193-4. PubMed ID: 24394845
    [No Abstract]   [Full Text] [Related]  

  • 14. An effective antioxidant drug on prevention of the necrosis of zone of stasis: N-acetylcysteine.
    Deniz M; Borman H; Seyhan T; Haberal M
    Burns; 2013 Mar; 39(2):320-5. PubMed ID: 22853970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vivo and in vitro study on the protective effects of N-acetylcysteine on mitochondrial dysfunction in isoproterenol treated myocardial infarcted rats.
    Basha RH; Priscilla DH
    Exp Toxicol Pathol; 2013 Jan; 65(1-2):7-14. PubMed ID: 21641783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine for the management of anemia and oxidative stress in hemodialysis patients.
    Hsu SP; Chiang CK; Yang SY; Chien CT
    Nephron Clin Pract; 2010; 116(3):c207-16. PubMed ID: 20606481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous N-acetylcysteine in the prevention of contrast media-induced nephropathy.
    Anderson SM; Park ZH; Patel RV
    Ann Pharmacother; 2011 Jan; 45(1):101-7. PubMed ID: 21205947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ Use of N-acetylcysteine for the prevention of contrast-induced nephropathy in rats].
    Inci MF; Salk I; Solak O; Vurdem UE; Inci R
    Actas Urol Esp; 2012 Apr; 36(4):210-5. PubMed ID: 22548227
    [No Abstract]   [Full Text] [Related]  

  • 19. Antioxidants and sepsis: can we find the ideal approach?
    Ritter C; Andrades M; Moreira JC; Dal-Pizzol F
    Crit Care Med; 2004 Jun; 32(6):1445-6; author reply 1446. PubMed ID: 15187562
    [No Abstract]   [Full Text] [Related]  

  • 20. Idiopathic pneumonia after marrow transplantation: when are antioxidants effective?
    Haddad IY
    Am J Respir Crit Care Med; 2002 Dec; 166(12 Pt 1):1532-4. PubMed ID: 12471068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.